Clinical Trials Directory

Trials / Conditions / Recurrent Childhood Visual Pathway Glioma

Recurrent Childhood Visual Pathway Glioma

13 registered clinical trials studyying Recurrent Childhood Visual Pathway Glioma.

StatusTrialSponsorPhase
CompletedPomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tu
NCT02415153
National Cancer Institute (NCI)Phase 1
Terminated18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
NCT02175745
Erik MittraN/A
WithdrawnEfficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
NCT02194452
Sue O'DorisioN/A
CompletedLow-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pil
NCT01553149
National Cancer Institute (NCI)Phase 2
TerminatedGamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T
NCT01088763
National Cancer Institute (NCI)Phase 1
CompletedVorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent
NCT00994500
National Cancer Institute (NCI)Phase 1
CompletedPazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Tr
NCT00929903
National Cancer Institute (NCI)Phase 1
CompletedBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagn
NCT00638898
City of Hope Medical CenterPhase 1
CompletedAZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
NCT00326664
National Cancer Institute (NCI)Phase 1
CompletedOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
NCT00101270
National Cancer Institute (NCI)Phase 1
CompletedCollecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
NCT00919750
Children's Oncology Group—
CompletedFlavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
NCT00012181
National Cancer Institute (NCI)Phase 1
CompletedIrinotecan in Treating Children With Refractory Solid Tumors
NCT00004078
Children's Oncology GroupPhase 2